ArticleCureus2025
A Case of Spinal Cord Stimulation Therapy for Lower Limb Pain Due to Conus Medullaris Syndrome.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This case report discusses the effective use of spinal cord stimulation (SCS) to treat lower limb pain caused by conus medullaris syndrome. A 49-year-old woman presented with persistent right lower limb pain and numbness following laparoscopic colon resection surgery. During epidural anesthesia, she experienced electric shock-like pain, which continued after surgery. MRI revealed fluid around the T12 thoracic spinal cord, suggesting spinal injury. Despite initial treatments, including epidural and nerve root blocks, the pain persisted. Further intervention with SCS led to significant pain reduction and improved mobility, enabling the patient to engage in rehabilitation. Conus medullaris syndrome, typically involving the T11-T12 to L2 spinal cord levels, can cause varied symptoms, including muscle weakness, atrophy, and radicular pain. In this case, the injury at the T11-T12 level presented with pain localized to the L2-L3 nerve root area, complicating the diagnosis. SCS, known for its efficacy in managing neuropathic pain, proved to be a suitable treatment for this patient, whose pain was refractory to conservative therapies. The treatment led to sustained pain relief and facilitated rehabilitation. This case highlights the diagnostic difficulties associated with conus medullaris syndrome; the symptoms of this condition may be similar to those of other conditions such as spinal pain. In this case, SCS was highly effective in treating neuropathic pain associated with spinal cord injury. In conclusion, SCS therapy provides significant relief for patients with conus medullaris syndrome, underscoring its importance in the management of chronic intractable neuropathic pain.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.